文献速递乳房整形与再造

乳房再造术后阿片类药物使用障碍的发生:尼古丁暴露的影响

Development of Opioid Use Disorder After Breast Reconstruction: Effects of Nicotine Exposure.
PubMed 文献 · Ann Plast Surg · 2024-01-01

本研究利用TriNetX多机构去标识数据库进行回顾性分析,纳入接受乳房再造术并术后使用阿片类药物的患者共8648例,匹配后吸烟组与不吸烟组各4324例。结果显示,术前吸烟与术后12、24、36个月阿片类药物使用障碍风险升高相关(36个月OR 2.722,CI 2.268-6.375),并与HIV、HCV及HBV感染风险升高相关。作者认为吸烟者术后至少3年内上述风险持续存在,需要进一步研究和临床干预。

要点

  • 术前吸烟与乳房再造术后36个月阿片类药物使用障碍风险升高相关(OR 2.722,CI 2.268-6.375)。
  • 吸烟还与术后各时间点HIV和HCV风险升高相关(36个月HIV OR 2.614,CI 1.977-3.458;HCV OR 3.718,CI 2.268-6.375)。
  • 吸烟与术后24个月起HBV风险升高相关(36个月OR 2.722,CI 1.502-4.935)。

核心结论

  • 吸烟者在乳房再造术后发生阿片类药物使用障碍、HIV、HCV和HBV的风险升高,且该风险至少持续至术后3年。
  • 作者认为需要进一步研究和临床干预,聚焦于阿片类药物使用障碍的早期识别、预防措施及对吸烟或尼古丁依赖患者的危害减少策略。

研究设计与样本

  • 回顾性分析,使用TriNetX多机构去标识数据库。
  • 纳入接受乳房再造术并接受术后阿片类药物治疗的患者,排除已有阿片类药物使用障碍或相关疾病者。
  • 暴露组为吸烟患者,对照组为不吸烟患者,队列经匹配以控制年龄、性别、种族、精神健康史及合并物质使用等混杂因素。
  • 共纳入8648例患者,匹配后暴露组4324例,对照组4324例。
  • 比较术后12至36个月阿片类药物使用障碍、HBV、HCV和HIV的发生风险。

主要发现

  • 术前吸烟与乳房再造术后12、24、36个月阿片类药物使用障碍风险升高显著相关(36个月OR 2.722,CI 2.268-6.375)。
  • 吸烟与术后所有时间点HIV风险升高相关(36个月OR 2.614,CI 1.977-3.458)。
  • 吸烟与术后所有时间点HCV风险升高相关(36个月OR 3.718,CI 2.268-6.375)。
  • 吸烟与术后24个月起HBV风险升高相关(36个月OR 2.722,CI 1.502-4.935)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: After undergoing breast reconstructive surgery, patients are typically prescribed opioids. Smoking tobacco increases rate of opioid metabolism and is associated with development of opioid use disorder (OUD). The aim of this study was to determine whether patients who smoke have an increased risk of OUD after breast reconstructive surgery. Given that OUD is a known risk factor for injection drug use and intravenous drug use increases risk of acquiring blood-borne diseases including human immunodeficiency virus (HIV) and hepatitis, the secondary aim was to determine if these patients are also at increased risk of acquiring these communicable diseases associated with OUD. METHODS: A retrospective analysis was conducted using TriNetX, a multi-institutional deidentified database. Individuals included underwent a breast reconstructive surgery and received postoperative opioid treatment. The exposed group included patients who smoke. The control group did not smoke. Risk of developing OUD, hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV from 12 to 36 months after surgery was compared between groups. Patients with preexisting OUD or associated diseases were excluded. Cohorts were matched to control for confounding factors including age, sex, race, mental health history, and concomitant substance use. RESULTS: There were 8648 patients included in the analysis. After matching, 4324 patients comprised the exposure group, and 4324 patients remained in the control group. Preoperative smoking was significantly associated with increased risk of OUD at 12, 24, and 36 months after breast reconstruction (36 months: odds ratio [OR], 2.722; confidence interval [CI], 2.268-6.375). Smoking was also associated with increased risk of HIV and HCV at all time points after surgery (36 months HIV: OR, 2.614; CI, 1.977-3.458; 36 months HCV: OR, 3.718; CI, 2.268-6.375) and increased risk of HBV beginning at 24 months after surgery (36 months HBV: OR, 2.722; CI, 1.502-4.935). CONCLUSIONS: Individuals who smoke have an increased risk of developing OUD, HIV, HCV, and HBV after breast reconstructive surgery. This risk persists for at least 3 years after surgery. Additional research and clinical interventions focusing on early identification of OUD, prevention efforts, and harm reduction strategies for patients who smoke or have nicotine dependence undergoing breast reconstruction are warranted.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Groff D, Freedman Z, Gilles A, et al. Development of Opioid Use Disorder After Breast Reconstruction: Effects of Nicotine Exposure. Ann Plast Surg. 2024. PMID: 38556681. doi:10.1097/SAP.0000000000003793

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。